Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 19, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Predicting Clinical Outcomes Using Molecular Biomarkers.

Harry B Burke¹

¹Professor of Medicine, Department of Medicine, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Biomarkers in Cancer

|June 10, 2016

Summary

This summary is machine-generated.

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

EBM BLS: Patients on Long Term Oral Anticoagulation Who Received Low Dose Aspirin for Chronic Coronary Syndrome Had A Higher Risk of Major Bleeding and Death.

Journal of general internal medicine·2026

Same author

Comparing audiovisual visit and in-person visit note quality.

JAMIA open·2026

Same author

Accuracy of large language model transcription of simulated physician-patient verbal interactions.

BMC medical informatics and decision making·2026

Same author

Association of hormone replacement therapy and image-detected breast cancer.

Frontiers in oncology·2025

Same author

EBM BLS: Tirzepatide Helps Obese Patients Lose Weight.

Journal of general internal medicine·2025

Same author

Individual heart failure patient variability in nocturnal hypoxia and arrhythmias.

Medicine·2024

Molecular biomarkers show promise but face adoption challenges. A new approach aims to improve their clinical use for personalized medicine, enhancing patient outcomes and clinical decision-making.

Area of Science:

Biomarkers and Personalized Medicine
Clinical Decision Support
Molecular Diagnostics

Background:

Exponential growth in biomarker research with over 768,000 PubMed-indexed papers.
Limited clinical translation of numerous reported molecular biomarkers.
Barriers to adoption include inadequate understanding, clinical assessment, and utilization.

Purpose of the Study:

To present a general approach for predicting clinical outcomes using molecular biomarkers.
To address the gap between biomarker discovery and clinical application.
To highlight the future role of biomarkers in advancing medical practice.

Main Methods:

A conceptual framework for understanding molecular biomarker utility.
Focus on risk, diagnostic, and prognostic biomarker applications.

Keywords:

biomarker cancer clinical outcome molecular outcome prediction surrogate outcome translation treatment

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Related Experiment Videos

Last Updated: Mar 19, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Emphasis on clinical assessment and integration into healthcare.

Main Results:

A straightforward approach to predicting clinical outcomes is proposed.
Identifies key areas for improving biomarker integration into clinical workflows.
Outlines the potential for molecular biomarkers to revolutionize patient care.

Conclusions:

Molecular biomarkers are poised to drive future advancements in disease risk, diagnosis, and prognosis.
Biomarkers will become central to targeted therapies and personalized treatment optimization.
Integration into clinical decision-making will enhance patient care and outcomes.